Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present MorphoSys AG (NASDAQ: MOR).

Full DD Report for MOR

You must become a subscriber to view this report.


Recent News from (NASDAQ: MOR)

Books will close today April 3, 2018.
Books will close today April 3, 2018.
Source: OTC Markets
Date: April, 03 2018 00:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-174,9668,67657.2384Short
2018-08-167,5819,54379.4404Short
2018-08-154,4128,41252.4489Short
2018-08-142,7534,11866.8528Short
2018-08-134,1146,18466.5265Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MOR.


About MorphoSys AG (NASDAQ: MOR)

Logo for MorphoSys AG (NASDAQ: MOR)

MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other proprietary technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest growing drug classes in human healthcare. Together with its partners in the pharmaceutical industry, MorphoSys has built a therapeutic pipeline of drug candidates for the treatment of cancer, rheumatoid arthritis, and Alzheimer s disease, to name just a few. With its ongoing commitment to new antibody technology and drug development, MorphoSys is focused on making the healthcare products of tomorrow. Over therapeutic antibody programs based on the company s technologies are currently in development, of which are in clinical trials. The company s most advanced proprietary program is MOR , a first in class antibody against GM CSF for the treatment of rheumatoid arthritis and multiple sclerosis. MOR is part of MorphoSys s collaboration with GlaxoSmithKline. Other proprietary clinical programs include MOR and MOR , both for the treatment of cancer. MorphoSys is listed on the Frankfurt Stock Exchange under the symbol MOR.

 

Contact Information

 

 

Current Management

  • Simon Moroney / CEO
  • Jens Holstein / CFO
  • Claudia GutjahrLoser / VP, Corp. Comm., VP, Investor Rel.
  • Arndt Schottelius / Chief Development Officer

Current Share Structure

     



    Daily Technical Chart for (NASDAQ: MOR)

    Daily Technical Chart for (NASDAQ: MOR)


    Stay tuned for daily updates and more on (NASDAQ: MOR)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: MOR)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MOR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of MOR and does not buy, sell, or trade any shares of MOR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/